Cost-utility of a modality of "C" virus hepatitis treatment in patients that do not respond to interferon plus ribavirin in Mexico

被引：0
|
作者：
Nevarez-Sida, A [1 ]
Constantino-Casas, P [1 ]
Garcia-Contreras, F [1 ]
机构：
[1] Mexican Inst Social Secur, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64451-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A47 / A47
页数：1
相关论文
共 50 条
  • [1] Liver transplant patients with hepatitis C who do not respond to pegylated interferon plus ribavirin do respond to consensus interferon plus ribavirin
    Joshi, Shobha N.
    Regenstein, Fredric G.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S223 - S223
  • [2] Do patients with Hepatitis C and Porphyria Cutanea Tarda respond to treatment with interferon and ribavirin?
    Chelamcharla, M
    Ramrakhiani, S
    Bacon, BR
    Befeler, AS
    [J]. GASTROENTEROLOGY, 2002, 123 (01) : 78 - 78
  • [3] Cost-utility of chronic hepatitis "C" treatment with thymosin alpha 1 in Mexico
    Nevárez-Sida, A
    Garcia-Contreras, F
    Constantino-Casas, P
    Castro-Rios, A
    Mould, J
    Garduño-Espinosa, J
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 309 - 309
  • [4] Efficacy of interferon plus ribavirin in the treatment of hepatitis C virus genotype 5
    Antaki, N.
    Hermes, A.
    Hadad, M.
    Ftayeh, M.
    Antaki, F.
    Abdo, N.
    Kebbewar, K.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2008, 15 (05) : 383 - 386
  • [5] Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon
    Mazzaro, C
    Zorat, F
    Comar, C
    Nascimben, F
    Bianchini, D
    Baracetti, S
    Donada, C
    Donadon, V
    Pozzato, G
    [J]. JOURNAL OF RHEUMATOLOGY, 2003, 30 (08) : 1775 - 1781
  • [6] TREATMENT EFFICACY OF PEGYLATED INTERFERON PLUS RIBAVIRIN IN PATIENTS INFECTED WITH GENOTYPE 6 HEPATITIS C VIRUS
    Shin, S. R.
    Park, S. H.
    Lee, M. S.
    Lee, J. W.
    Lee, J. S.
    Kim, Y. S.
    Choi, M. S.
    Kim, S. M.
    Jeong, S. -H.
    Shon, J. H.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S480 - S480
  • [7] Treatment with amantadine plus ribavirin plus interferon in patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy.
    Ferenci, P
    Stauber, R
    Hackl, F
    Schuetze, K
    Bauer, B
    Datz, C
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A1437 - A1437
  • [8] Effects of Host and virus related factors on Interferon-α plus ribavirin and Pegylated-interferon plus ribavirin treatment outcomes in Chronic Hepatitis C patients
    Akram, Madiha
    Idrees, Muhammad
    Zafar, Shamail
    Hussain, Abrar
    Butt, Sadia
    Afzal, Samia
    Rehman, Irshad-ur
    Liaqat, Ali
    Saleem, Sana
    Ali, Muhammad
    Butt, Azeem
    [J]. VIROLOGY JOURNAL, 2011, 8
  • [9] Cost-utility analysis of different peg-interferon alpha-2b plus ribavirin treatment strategies as initial therapy for naive Chinese patients with chronic hepatitis C
    Lin, W. -A.
    Tarn, Y. -H.
    Tang, S. -L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (10) : 1483 - 1493
  • [10] Treatment of hepatitis C virus genotype 2 and 3 with pegylated interferon plus ribavirin
    Rizzetto, M
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 (02) : 275 - 276
12345